Influence of the - 675 4G/ 5G dimorphism of the Plasminogen activator inhibitor 1 promoter on thrombotic risk - Egyptian Knowledge Bank - troweb

39654

Influence of the - 675 4G/ 5G dimorphism of the Plasminogen activator inhibitor 1 promoter on thrombotic risk

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Genetic variation in coagulation factors and their impact on arterial and venous thrombosis

Thesis

The role of plasma homocysteine and its genetic control as risk factors for thrombophilia

Thesis

Association of Factor XII genotypic polymorphism and phenotype with risk of venous thrombosis

Thesis

Impact of prothrombotic risk factors on the clinical phenotype in haemophilia patients

Thesis

Study of methylenetetraydrofolate reductase gene mutation as a risk factor for deep venous thrombosis

Thesis

Thrombin-activatable fibrinolysis inhibitor gene polymorphism in IHD, Diagnostic and prognostic correlation

Thesis

Study of the coagulation factor VII gene polymorphism in patients undergoing coronary catheter intervention

Thesis

Evaluation of plasma plasminogen activator inhibitor-1 (PAI-1) in type II diabetes mellitus

Thesis

Protein Z gene polymorphisms & protein Z plasma levels in preeclamptic patients

Thesis

Study of factor V liden in thromboembolic patients